FDA seeks additional trial on Zalviso drug-device combo from AcelRx March 9, 2015 By MassDevice Contributors Network Leave a Comment (Reuters) — AcelRx Pharmaceuticals (NSDQ:ACRX) said the FDA wants an additional study on its Zalviso drug-device combination, which the safety watchdog already rejected once last year.